Investors
Key investment highlights in AlzeCure
- Targeting areas of huge unmet medical needs
- Strong team with extensive experience and track record
- Platforms with first-in-class properties and potential game-changers
- Parallel investments in several candidates and potent follow-up programs
- Multi-billion dollar market opportunity areas
Press releases
-
AlzeCure Pharma publishes its Annual Report for 2020
April 6, 2021
-
AlzeCure analyst coverage initiated by Edison Investment Research
March 24, 2021
-
AlzeCure publishes its Year-end report for 2020
February 26, 2021
Financial reports
-
AlzeCure Pharma publishes its Annual Report for 2020
April 6, 2021
-
AlzeCure publishes its Year-end report for 2020
February 26, 2021
-
AlzeCure publishes its interim report for January – September 2020
November 17, 2020